Biosensors Market By Product 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Biosensors Market
Biosensors Market: By Product (Wearable & Non-Wearable); By Technology (Electrochemical, Piezoelectric, Optical, Thermal, Others); By Application (Medical, Agriculture, Environment, Others); By End-User (Point-of-Care, Home Diagnostics, Others)-Forecast(2016-2021)
Report Code : HCR 0160
Updated Date: 25 February, 2016  

  • Report Description
  • Table of Contents
  • Customization Options
1. Biosensors – Market Overview
2. Executive Summary 
3. Biosensors Market Landscape
   3.1. Market Share Analysis
   3.2. Comparative Analysis
   3.3. Product Benchmarking
   3.4. End User Profiling
   3.5. Top 5 Financials Analysis
4. Biosensors – Market Forces
   4.1. Drivers
      4.1.1. Development of nanotechnology/nanobiosensors
      4.1.2. Rise in the demand for home based POC devices
      4.1.3. Increasing glucose monitoring in diabetic’s patients
   4.2. Restraints
      4.2.1. The research and development having higher cost
      4.2.2. Lack of standardization
   4.3. Opportunities
      4.3.1. Emerging economies
      4.3.2. Increase in adoption of biosensors for non-medical applications, such as- the food industry, environmental monitoring, and biodefense
   4.4. Challenges
   4.5. Porter’s Five Forces Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Buyers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. Biosensors Market, By Product 
   5.1. Wearable Biosensors
   5.2. Non-Wearable Biosensors 
6. Biosensors Market, By Technology 
   6.1. Electrochemical Biosensors
   6.2. Piezoelectric Biosensors
   6.3. Optical Biosensors 
   6.4. Thermal Biosensors
   6.5. Others
7. Biosensors Market, By Application 
   7.1. Medical
   7.2. Food Toxicity Detection
   7.3. Industrial Process Control
   7.4. Agriculture
   7.5. Environment
   7.6. Others
8. Biosensors Market, By End-User 
   8.1. Point-of-Care
   8.2. Home Diagnostics
   8.3. Research Labs 
   8.4. Biodefense
   8.5. Environmental Monitoring 
   8.6. Food Industry
   8.7. Others
9. Biosensors Market, By Geography
   9.1. Europe
      9.1.1. Germany
      9.1.2. France
      9.1.3. Italy
      9.1.4. Spain
      9.1.5. Russia
      9.1.6. U.K.
      9.1.7. Rest of Europe
   9.2. Asia Pacific
      9.2.1. China
      9.2.2. India
      9.2.3. Japan
      9.2.4. South Korea
      9.2.5. Rest of Asia-Pacific
   9.3. North America 
      9.3.1. U.S.
      9.3.2. Canada
      9.3.3. Mexico
   9.4. Rest of the World (RoW)
      9.4.1. Brazil
      9.4.2. Rest of RoW
10. Biosensors – Market Entropy
   10.1. Expansion
   10.2. Technological Developments
   10.3. Merger & Acquisitions, and Joint Ventures
   10.4. Supply- Contract
11. Company Profiles
   11.1. Abbott Point of Care, INC.
      11.1.1. Introduction
      11.1.2. Financials
      11.1.3. Key Insights
      11.1.4. Key Strategy
      11.1.5. Product Portfolio
      11.1.6. SWOT Analysis
   11.2. Acon Laboratories, INC.
      11.2.1. Introduction
      11.2.2. Financials
      11.2.3. Key Insights
      11.2.4. Key Strategy
      11.2.5. Product Portfolio
      11.2.6. SWOT Analysis
   11.3. Bayer AG
      11.3.1. Introduction
      11.3.2. Financials
      11.3.3. Key Insights
      11.3.4. Key Strategy
      11.3.5. Product Portfolio
      11.3.6. SWOT Analysis
   11.4. F. Hoffman La-Roche LTD.
      11.4.1. Introduction
      11.4.2. Financials
      11.4.3. Key Insights
      11.4.4. Key Strategy
      11.4.5. Product Portfolio
      11.4.6. SWOT Analysis
   11.5. Lifescan, INC.
      11.5.1. Introduction
      11.5.2. Financials
      11.5.3. Key Insights
      11.5.4. Key Strategy
      11.5.5. Product Portfolio
      11.5.6. SWOT Analysis
   11.6. Medtronic INC.
      11.6.1. Introduction
      11.6.2. Financials
      11.6.3. Key Insights
      11.6.4. Key Strategy
      11.6.5. Product Portfolio
      11.6.6. SWOT Analysis
   11.7. Nova Biomedical Corporation
      11.7.1. Introduction
      11.7.2. Financials
      11.7.3. Key Insights
      11.7.4. Key Strategy 
      11.7.5. Product Portfolio
      11.7.6. SWOT Analysis
   11.8. Pharmaco-Kinesis Corporation
      11.8.1. Introduction
      11.8.2. Financials
      11.8.3. Key Insights
      11.8.4. Key Strategy
      11.8.5. Product Portfolio
      11.8.6. SWOT Analysis
   11.9. Siemens AG
      11.9.1. Introduction
      11.9.2. Financials
      11.9.3. Key Insights
      11.9.4. Key Strategy
      11.9.5. Product Portfolio
      11.9.6. SWOT Analysis
   11.10. Universal Biosensors
      11.10.1. Introduction
      11.10.2. Financials
      11.10.3. Key Insights
      11.10.4. Key Strategy
      11.10.5. Product Portfolio
      11.10.6. SWOT Analysis
*More than 10 Companies are profiled in this Research Report*
"*Financials would be provided on a best efforts basis for private companies"
12. Appendix
   12.1. Abbreviations
   12.2. Sources
   12.3. Research Methodology
   12.4. Bibliography
   12.5. Compilation of Expert Insights
   12.6. Disclaimer
Biosensors provide qualitative and quantitative data for the real-time analysis and play a very important role to sense the biological environment. A biosensor is bioelectronics analytical tool that captures the biological signal from analyte by using a physicochemical detector and translate these signals into measurable outputs. Globally, development of nanotechnology/nanobiosensors, rise in the demand for home based POC devices, and increasing glucose monitoring in diabetic’s patients are the prime growth drivers of biosensors market. In addition, increase in adoption of biosensors for non-medical applications, such as- the food industry, environmental monitoring, and biodefense and, emerging economies such as China, India and others, will create new opportunities for biosensors market. However, higher cost of the research and development, and lack of standardization are the key restraints for biosensors market.

This report identifies the global biosensors market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to global biosensors market.
Biosensors Market

Geographically North America dominated biosensors market, and Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population, and modernizing healthcare infrastructure in this region. Among all the end-users, point of care testing segment has the highest market share in biosensors market.

This report segments biosensors market on the basis of product, technology, application, end-user, and regional market as follows:
  • Biosensors Market, By Product: Wearable Biosensors, and, Non-Wearable Biosensors
  • Biosensors Market, By Technology: Electrochemical Biosensors, Piezoelectric Biosensors, Optical Biosensors, Thermal Biosensors, and Others
  • Biosensors Market, By Application: Medical, Food Toxicity Detection, Industrial Process Control, Agriculture, Environment, and Others
  • The report has focused study on biosensors market by basis of end-user such as: Point-of-Care, Home Diagnostics, Research Labs, Biodefense, Environmental Monitoring, Food Industry, and Others
  • This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region

Sample Companies Profiled in this Report are:
  • Abbott Point of Care, INC.
  • Acon Laboratories, INC.
  • Bayer AG
  • F. Hoffman La-Roche LTD.
  • Lifescan, INC.
  • 10+.
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports